T1␣, a differentiation gene of lung alveolar epithelial type I cells, is developmentally regulated and encodes an apical membrane protein of unknown function. Morphological differentiation of type I cells to form the air-blood barrier starts in the last few days of gestation and continues postnatally. Although T1␣ is expressed in the foregut endoderm before the lung buds, T1␣ mRNA and protein levels increase substantially in late fetuses when expression is restricted to alveolar type I cells. We generated T1␣ null mutant mice to study the role of T1␣ in lung development and differentiation and to gain insight into its potential function. Homozygous null mice die at birth of respiratory failure, and their lungs cannot be inflated to normal volumes. Distal lung morphology is altered. In the absence of T1␣ protein, type I cell differentiation is blocked, as indicated by smaller airspaces, many fewer attenuated type I cells, and reduced levels of aquaporin-5 mRNA and protein, a type I cell water channel. Abundant secreted surfactant in the narrowed airspaces, normal levels of surfactant protein mRNAs, and normal patterns and numbers of cells expressing surfactant protein-B suggest that differentiation of type II cells, also alveolar epithelial cells, is normal. Anomalous proliferation of the mesenchyme and epithelium at birth with unchanged numbers of apoptotic cells suggests that loss of T1␣ and/or abnormal morphogenesis of type I cells alter the proliferation rate of distal lung cells, probably by disruption of epithelial-mesenchymal signaling.
Introduction
T1␣ is a differentiation gene highly expressed by type I epithelial cells lining most of the gas exchange surface of the lung (Dobbs et al., 1988) . As one of the first marker genes for the alveolar type I cell to be identified at the molecular level, there is considerable information about regulation of its expression in normal and diseased lung, and about gene and protein structure (Cao et al., 2000; Koslowski et al., 1998; Ma et al., 1998; McElroy et al., 1995 McElroy et al., , 1997 Ramirez et al., 1997 Ramirez et al., , 1999 Rishi et al., 1995; Vanderbilt and Dobbs, 1998; Williams et al., 1996) . However, the function of the protein is unknown even though it is a major lung protein in terms of abundance. Sequence analysis indicates that T1␣ protein does not share common domains with other protein families of known function that could predict its function.
T1␣ gene expression is developmentally regulated (Rishi et al., 1995; Williams et al., 1996) . T1␣ protein is detected in the mouse foregut endoderm before the lung buds (embryonic day E8.5-9.0) (unpublished results). During lung morphogenesis, its expression pattern changes from widespread in embryonic lung epithelium to one in which expression is restricted to type I cells of the distal epithelium. The levels of T1␣ mRNA and protein in the lung are highly up-regulated at the end of gestation, when morphogenesis of type I cells occurs. Although type II epithelial cells also reside in the alveolar epithelium, they do not express T1␣ (Cao et al., 2000; Dobbs et al., 1988; McElroy et al., 1995; Williams et al., 1996) . T1␣ is also expressed in the developing nervous system. In contrast to lung, there are high levels of expression in the early neural tube but, by midgestation, the gene is down-regulated, being detected in the adult brain only in the choroid plexus (Ramirez et al., 1999; Wetterwald et al., 1996; Williams et al., 1996) .
Although the adult lung and embryonic brain express the most T1␣ mRNA, lesser amounts are expressed in adult rodents in kidney, bone, lymphatic endothelium, and thymus (Breiteneder-Geleff et al., 1997 Farr et al., 1992; Nose et al., 1990; Ramirez et al., 1999; Rishi et al., 1995; Wetterwald et al., 1996; Williams et al., 1996) and in a subset of cells obtained from murine bone marrow (Kotton et al., 2001) .
Computer analysis of the rodent T1␣ sequence shows that the protein has putative extracellular and transmembrane domains, consistent with its localization in the type I cell apical plasma membrane, and a short cytoplasmic tail with putative PKC and cAMP phosphorylation sites (Ma et al., 1998; Rishi et al., 1995) . The protein is highly Oglycosylated and contains sialic acid (Gonzalez and Dobbs, 1998) . Homologous genes have been cloned in several systems. The proteins RT140 (McElroy et al., 1995) , rat podoplanin (Breiteneder-Geleff et al., 1997) , and E11 antigen are identical to rat T1␣; the partial cDNA OTS-8 (Nose et al., 1990) , and proteins gp38 (Farr et al., 1992) and PA2.26 (Scholl et al., 1999) , are identical to mouse T1␣. In addition canine (Zimmer et al., 1997) and human (Ma et al., 1998; Zimmer et al., 1999) sequences with moderate levels of homology have been identified.
The physiological role of T1␣ has not yet been determined. Based on expression patterns, several functions can be hypothesized. Developmental expression patterns suggest that T1␣ might influence formation of the bronchial tree or the central nervous system. In the adult, since it is expressed by a number of tissues involved in fluid fluxes and is coexpressed with some aquaporins, T1␣ could be a regulator of fluid transport. Finally the location of T1␣ on the type I cell apical membrane, a surface area of large magnitude (Ͼ70 m 2 in the adult human), raises the possibility that it interacts with molecules or cells present in alveolar lumens.
We generated T1␣ null mice containing a targeted mutation in the T1␣ gene locus. Homozygous null mutant mice [T1␣ (Ϫ/Ϫ)] die at birth of respiratory failure. No gross morphological abnormalities of lung or brain are observed in newborns. However, histologic and molecular analyses of the lung at birth show an abnormally high expression of proliferation markers in the distal lung, many fewer attenuated type I cells, narrower and irregular air spaces, and defective formation of alveolar saccules in homozygous animals compared to wild-type littermates [T1␣ (ϩ/ϩ)]. This phenotype suggests that the loss of T1␣ affects the regulation of peripheral lung cell proliferation in the perinatal period and interferes with differentiation of type I cells that line the potential air spaces. Although a detailed analysis of the homozygous brain at term has not been completed, no obvious abnormalities have been observed.
Materials and methods

Targeting vector
A 12-kb EcoR1 fragment, spanning the 5Ј flanking region, the 5Ј untranslated region (5ЈUTR)-first exon, and part of the first intron, was characterized by restriction enzyme and Southern blot analyses of a BAC clone containing the mouse T1␣ gene (mouse T1␣ ϭ OTS-8 Accession No. M73748) (Incyte Genomics Inc.). This fragment was subcloned into p-BluescriptSK (Stratagene) and partially sequenced. To generate the targeting vector, a 5Ј arm of homology (ϳ2 kb fragment in the T1␣ promoter from Ϫ3.5 to Ϫ1.5 kb) was obtained by PCR (forward primer 5Ј CTGACTCGAGTAGCAACAGCCACCAACG3Ј, reverse primer 5ЈCTGACTCGAGCCAATGAAGGTGACAAT-GAGC3Ј) and its sequence was confirmed by comparison to the original BAC clone. The 3Ј arm of homology was a Nar1-Ssp1 fragment spanning 4 kb in the first intron. Arms were designed to replace ϳ1.5 kb of the promoter, 210 bp of the UTR, the first exon (67 bp), and 181 bp of the first intron. Arms were cloned in a vector (pLNTK) containing pGK-Neo and pGK-HSVtk, positive and negative selection genes (kindly provided by Dr. G. Taccioli, Boston University School of Medicine, Boston, MA) (Taccioli et al., 1998) .
T1␣ gene targeting
The linearized targeting vector was electroporated into 129/SvEv TC1 ES cells (Deng et al., 1994; Xu et al., 1999) . Two of 102 clones that survived selection in G418 and FIAU had undergone homologous recombination as determined by Southern blot. Cells from these clones were injected into C57BL/6 blastocysts and implanted into foster mothers in the Boston University School of Medicine transgenic facility. Chimeric males were mated to 129/SvEv females for germline transmission of the mutated T1␣ allele. Southern blots of EcoR1-digested genomic DNA were used to identify mutant mice. Probes external to the 5Ј and 3Ј arms and a Neo probe were generated by PCR (oligonucleotides to amplify the 5Ј-probe were forward 5ЈAAGCCAG-GTTCCCACTCATAG3Ј, reverse 5Ј GTATCAGGTCAT-TCTCCCTTC3Ј; oligonucleotides to amplify the 3Ј-probe were forward 5ЈTGCCTACTGCCATGCTTCTACC3Ј, reverse 5Ј CTACACCATAGTTATCGCTC3Ј 
Lung wet/dry weight ratio and DNA content
Newborn lungs were dissected and weighed. To determine wet/dry weight ratios, lungs were dissected in two fragments and weighed. One fragment was dried to constant weight in a SpeedVac at room temperature. The second fragment was used to purify genomic DNA as described previously (Ramirez et al., 1999) . DNA concentration was estimated by UV spectroscopy using A260/280 absorbances.
Lung histology
Newborn lungs were immersed in 2% glutaraldehyde, 1% paraformaldehyde, 0.15 M sodium cacodylate buffer for 16 -18 h, dehydrated, and embedded in either JB-4 or Epon 812 substitute resins (Polysciences, Inc.). JB-4 sections (2 m) were stained with hematoxylin and eosin (H&E) and Epon sections (0.5 m) were stained with toluidine blue.
Lung inflation
E19.5 fetal lungs were inflated with 4% paraformaldehyde/PBS fixative under pressure (15 cm H 2 O pressure) via a tracheal cannula of PE 20 tubing (Intramedic, Clay Adams) and 25-gauge blunt catheter. After inflation the thoracic cavity was filled with fixative. After 5 min, the lungs were removed, stored in fixative overnight at 4°C, and embedded in paraffin. Sections (6 m) were stained with H&E.
Northern blots
Northern blots were performed by previously described methods (Ramirez et al., 1999) using total RNA (5 or 10 g) from newborn lungs. Probes were 32 P-labeled. Mouse caveolin-1 (forward primer 5ЈTGTGATTGCAGAACCA-GAAGGG3Ј, reverse primer 5ЈGGAACTTGAAATTG-GCACCAGG3Ј) and carboxypeptidase-M (CP-M) (forward primer 5ЈGAGACTCTGGCAATCATGGAGTG3Ј, reverse primer 5ЈGCGAGGATATTTACAGCACGACAG3Ј) probes were generated by RT-PCR. VEGF probe, a 650-bp cDNA fragment of the 188-kDa isoform, was a gift of Dr. A. Healy, Boston University, Boston, MA. Other probes were described previously (Meneghetti et al., 1996; Ramirez et al., 2000) . Gene expression levels were determined in three to four blots, using mRNAs from different litters. Densitometry was performed in a Bio-Rad Fluor-S MultiImager. ␤-Actin was used to normalize data. Statistical analysis was performed using StatView 5.12 (BrainPower, Inc.). Data are expressed as mean Ϯ SEM. Statistical significance was analyzed using Student's t-test.
Western blots
Protein was extracted from lung homogenates using RIPA buffer as described previously . Protein (10 g) was electrophoresed on 12% polyacrylamide gels, transferred to PVDF membranes, blocked with 5% milk, and incubated overnight at 4°C with specific primary antibodies. T1␣ was detected with mAb 8.1.1 (dilution 1:200), a hamster monoclonal antibody (a gift of Dr. Andrew G. Farr, Department of Biological Structure, University of Washington School of Medicine, Seattle, WA) that recognizes the thymic protein gp38 identical to T1␣. This antibody labels alveolar type I cells in adult mouse lung by immunohistochemistry (Cao et al., unpublished data) . The mAb 8.1.1 is deposited in the Developmental Studies Hybridoma Bank (www.uiowa.edu/ϳdshbww/). HRP-labeled anti-hamster IgG (dilution 1:2500) (ICN) was used as a secondary antibody. CP-M was detected using an affinity-purified rabbit antibody to the N-terminal peptide of the human CP-M protein (dilution 1:2000) (a gift of Dr. Randal A. Skidgel, Department of Pharmacology, University of Illinois at Chicago); binding was detected with HRPlabeled anti-rabbit IgG (dilution 1:10,000). PCNA was detected with a murine monoclonal antibody NCL-PCNA (dilution 1:500) (Novocastra Laboratories) and an antimouse secondary antibody. HRP was developed using SuperSignal West Pico Chemiluminescent Substrate (Pierce). Total protein per well was used to normalize the data.
Protein for Aqp-5 Western blots was extracted from newborn lung homogenates by the methods of Korfhagen et al. in 500 l buffer containing protease inhibitors (Korfhagen et al., 1996) . Samples were centrifuged at 250g, 10 min at 2°C. Supernatants were ultracentrifuged at 135,000g for 4 h, and pellets were resuspended in homogenization buffer without sucrose (50 l). Newborn lung protein extracts (30 g) and adult lung protein extracts (10 g) were electrophoresed on 16% polyacrylamide gels, transferred to nitrocellulose, blocked, and incubated overnight at 4°C with an affinity-purified rabbit polyclonal Aqp-5 antibody (dilution 1:1000) (a gift of Dr. Alfred N. Van Hoek, Renal Unit, Massachusetts General Hospital, Charlestown, MA). HRPlabeled anti-rabbit IgG (dilution 1:6000) (ICN) was used as a secondary antibody.
Immunohistochemistry
Newborn lungs were fixed overnight by immersion in 4% paraformaldehyde in PBS at 4°C and embedded in paraffin as described . Sections (6 m) were deparaffinized and hydrated by standard methods. Endogenous peroxidase was quenched with 3% H 2 O 2 in methanol for 15 min. Blocking was performed with 2% normal goat serum in PBS/0.2% Triton X-100 for 2 h at room temperature. Tissues were exposed to primary antibodies in PBS for 16 h, 4°C. Washes were performed with PBS containing 0.2% Triton X-100 except where noted.
The following antibodies were used: rabbit anti-human prosurfactant-B (C-terminal) polyclonal antibody (Chemicon International, Inc.) (1:1000 dilution); anti-mouse goat polyclonal antibody SP-C (M-20) (Santa Cruz Biotechnology Inc.) (1:1000 dilution) (omitting Triton X-100); rabbit anti-Aqp-5 antibody (above) (1:100 dilution); anti-PE-CAM-1 (M-20) antibody (Santa Cruz Biotechnology Inc.) (1:1000 dilution), and stained as described previously (Ramirez et al., 2002) . For Aqp-5, antigen retrieval was performed for 20 min at 90°C using unmasking solution (Vector Laboratories, Inc.). Sections were washed with PBS/0.2% Triton X-100 and incubated 1 h at room temperature with a secondary antibody diluted in PBS/0.2% Triton X-100. Antibody binding was detected with the Vectastain Elite ABC kit using also PBS/0.2% Triton X-100 (Vector Laboratories, Inc.) and diaminobenzidine (DAB) as substrate. For some antibodies signals were enhanced using the TSA kit (NEN Life Science Products, Inc.). PECAM-1 staining was performed as described previously (Ramirez et al., 2002) . Control slides omitting the primary antibody were run simultaneously. Sections were counterstained with methyl green (Vector Laboratories, Inc.). PCNA was detected with the PCNA staining kit (Zymed) using a biotinylated primary antibody, HRP-streptavidin, and DAB substrate. Some sections were counterstained with H&E.
Apoptosis analysis
Apoptotic nuclei were detected by TUNEL staining of paraffin sections using the TdT-FragEL DNA fragmentation detection kit (Oncogene Research Products). The percentage of TUNEL-positive cells in two wild-type and two knockout lungs was determined by counting TUNEL-positive nuclei and total nuclei stained with methyl green in 10 fields using the 100ϫ objective lens and OpenLab software (Improvision, Inc.) with the density slice module and advanced measurement settings. Values were statistically analyzed as described above.
Results
Characterization of T1␣ null mutant mice
T1␣(ϩ/Ϫ) mice containing the null T1␣ gene locus were generated by crossing the initial chimeras to 129/SvEv wildtype mice (Fig. 1A) . T1␣(ϩ/Ϫ) mice were mated and litters genotyped (Fig. 1B) . The resultant litters have a Mendelian ratio of (1:1.8:0.75) (Table 1) at birth. The slightly lower number of T1␣(Ϫ/Ϫ) is not statistically significant ( 2 ϭ 0.23), indicating that the lack of T1␣ gene is not lethal during embryogenesis. Northern and Western blot analyses of newborn lung RNA and protein extracts show no T1␣ mRNA or protein in T1␣(Ϫ/Ϫ) mice, and reduction in the levels of T1␣ in T1␣(ϩ/Ϫ) mice (Fig. 1C and D) . No bands of smaller molecular weight were detected in either Northern or Western blots. By RT-PCR, no T1␣ mRNA was detected in T1␣(Ϫ/Ϫ) brain and kidney (data not shown) as expected.
Neonatal respiratory failure
Homozygous null mutant mice die at birth. Mice make a respiratory effort but are cyanotic and lethargic and only survive about 3-10 min, leading us to conclude that they die of respiratory failure. A few animals survived for up to 4 h before dying of apparent respiratory failure. The gross morphology, number of lobes, lung shape, and lung/body wet weight ratio of the T1␣(Ϫ/Ϫ) mice are similar to T1␣(ϩ/ϩ) littermates. On average, homozygous mice are slightly heavier (19%) than wild-type mice (Table 1 ). Although the difference is statistically significant (P Յ 0.01), the lung/ body weight ratios are conserved. The lungs of mice that die a few minutes after birth are not inflated (Figs. 2 and 3) , while those of longer survivors are partially inflated with small volumes of air. In these animals, air appears to be Note. P value Ϫ/Ϫ to ϩ/ϩ (n) number of mice a P Յ 0.01 b P Յ 0.02 c P Յ 0.07 trapped in the airways rather than in the peripheral lung, making the airways look distended (Fig. 3C ). Using the lectin Lycopersicum esculentum to delineate the contours of the potential airspaces confirms that the T1␣(Ϫ/Ϫ) lungs have narrower, irregular airspaces compared to T1␣(ϩ/ϩ) (data not shown). Heterozygous mice are viable, fertile, and have been maintained for more than a year in a pathogenfree area.
Altered distal lung morphology
Toluidine blue stained, 0.5-m plastic sections ( Fig. 4C  and D) show abundant secreted surfactant in air spaces of both wild-type and T1␣(Ϫ/Ϫ) animals. By EM, the secreted surfactant in both wild-type and T1␣(Ϫ/Ϫ) lungs is composed of lamellar bodies and tubular myelin with normal structural features (data not shown). The use of 0.5 m plastic sections also makes it possible to visualize very thin septae between airspaces and capillaries in the T1␣(Ϫ/Ϫ) lung ( Fig. 4A and B ), indicating that a few attenuated type I cells are present although infrequent. The presence in T1␣(Ϫ/Ϫ) lungs of a few type I cells with normal cellular characteristics has been confirmed by EM. Electron microscopy also demonstrates that the structure of type II cells is normal and that the cells contain lamellar bodies as expected.
We tested the distensibility of day E19.5 T1␣(Ϫ/Ϫ) lungs by instilling fixative under pressure via a tracheal cannula. We noted a small increase in dimensions of the peripheral lung lumens but did not observe expansion approaching that seen in wild-type animals ( Fig. 3D and E) .
Expression of differentiation marker genes in distal lung cells
Expression of differentiation genes was compared on Northern blots of wild-type, heterozygous, and homozygous lungs (Fig. 5) . We selected genes expressed by distal lung Table 2 . cells as follows: Aqp-5 (Funaki et al., 1998) and CP-M (Nagae et al., 1993) (Bhatt et al., 2000) expressed in type II cells and/or Clara cells in small bronchioles; CC10 expressed by Clara cells; and caveolin-1 expressed by alveolar type I cells and endothelial cells . We also analyzed expression of the fibroblast growth factors FGF-7 (Yano et al., 2000) , a lung epithelial cell mitogen, and FGF-10 (Bellusci et al., 1997) , an important regulator of epithelial branching during lung development.
expressed in type I cells; SP-A, -B, -C, and -D, and VEGF
Densitometric analyses of three to four Northern blots containing RNA from different groups of animals (Table 2) indicate that only Aqp-5 is significantly changed as indicated by a 2.3-fold decrease in T1␣(Ϫ/Ϫ) lungs compared to wild-type. Western blots of Aqp-5 protein confirm this decrease (Fig. 6) . The decrease in Aqp-5 mRNA and protein likely reflects the presence of many fewer attenuated type I cells in homozygous animals as shown histologically ( Fig.  7A and B) . Expression levels of other genes do not differ between wild-type and T1␣(Ϫ/Ϫ) animals. There is a small although not significant increase in caveolin-1 mRNA in homozygous lungs; whether it is up-regulated in epithelial or endothelial cells is not known. The levels of SP-A, -B, -C, and -D mRNAs are the same in wild-type and T1␣(Ϫ/Ϫ) animals, consistent with immunohistochemical findings with SP-B and SP-C antibodies showing that the patterns of expression of SP-B and SP-C are similar in wild-type and T1␣(Ϫ/Ϫ) lungs (Fig. 7C-F) . Likewise cell counts show that a similar percentage of total distal lung cells expresses SP-B protein in T1␣(Ϫ/Ϫ) lungs (8.3 Ϯ 0.83%) compared to wild-type (7.2 Ϯ 0.89%). Western blot analysis also shows that CP-M protein levels are not altered (Fig. 1D) . No differences are apparent in immunohistochemical expression patterns of PECAM-1 (Fig. 7G and H) , suggesting that endothelial cell differentiation is not markedly altered.
Cell proliferation and apoptosis in homozygous lungs
Immunostaining shows that there is a significantly higher number of PCNA-positive cells in the distal lung of mutant mice than in wild-type (Fig. 8A-G) . This indicates that cells in the T1␣(Ϫ/Ϫ) have proliferated in the 24 to 30-h period before birth while cells of wild-type animals have ceased proliferation as expected. The altered pattern of PCNAstained cells is reflected in Western blot analyses that show that PCNA protein levels are increased 1.8-fold in T1␣(Ϫ/Ϫ) compared to wild-type lungs (n ϭ 4, P Յ 0.02) (Fig. 6) . Wet/dry lung weight ratio and DNA content per dry weight were determined to see if enhanced PCNA staining was accompanied by an increase in cell number; both values are 40 -60% lower in T1␣(Ϫ/Ϫ) compared to wild-type (Table 1) . This suggests that, on average, cells in the T1␣(Ϫ/Ϫ) lung may be bigger than in the wild-type, or there may be increased abundance of extracellular matrix proteins or a combination of these.
Increased apoptosis could compensate for increased cell proliferation and thus conserve the size of the lung. However, quantitation of TUNEL-positive nuclei shows no difference in the percentage of apoptotic nuclei between T1␣(Ϫ/Ϫ) (1.5%) and wild-type (1.0%) lungs at birth (Fig.  8H and I ).
Discussion
We generated T1␣ null mutant mice to explore the function of T1␣ and to see if it plays a critical role in formation and maintenance of the air-blood barrier. T1␣ null mice die at birth, likely due to lung abnormalities present in newborns that impair respiration. 
These mice reveal that expression of the T1␣ gene is associated with, although not absolutely required for, the timely morphogenesis and differentiation of type I cells in the distal lung before birth. The lack of type I cells would be expected to reduce the surface area for gas exchange to a level below that required for survival of the newborn. However this cannot be the only defect leading to neonatal death because, despite attempts to breathe, T1␣(Ϫ/Ϫ) mice cannot inflate their lungs. Although the lungs look hypercellular, wet/dry and DNA/dry weight ratios argue against this and indicate that the homozygous null animals have a slightly reduced number of cells, a larger cell size, or both when compared to wild-type controls. These features could be a general sign of lung immaturity since it is known that the size of distal lung cells decreases in late gestation when cells lose glycogen and undergo morphogenesis to acquire their adult cellular characteristics (Adamson and Bowden, 1975; O'Hare and Townes, 1970) .
There is abnormal regulation of peripheral lung cell proliferation in T1␣ null mutant animals. PCNA staining shows a large excess of proliferating cells in T1␣(Ϫ/Ϫ) distal lung; PCNA protein levels are increased in homozygous null lungs analyzed by Western blot. In addition different cell populations are PCNA-positive in the knockout lung compared to the wild-type. Although the dense cellularity of the knockout lung makes identification of dividing cells problematic, proliferating cells can be recognized in both the distal epithelium and the adjacent connective tissues. There appear to be few PCNA-labeled endothelial cells. In the wild-type lungs PCNA-positive cells at term are almost completely restricted to blood vessels and airways, consistent with observations of a number of previous studies (Kauffman, 1975; Kauffman et al., 1974; O'Hare and Townes, 1970) .
The increased proliferation of peripheral lung cells in the term T1␣(Ϫ/Ϫ) differs markedly from the time course of the thymidine-labeling index (LI) reported for the normal lung (Kauffman, 1975; O'Hare and Townes, 1970) . During normal development, there is rapid cell proliferation during early and mid-gestational lung organogenesis; on gestational day 15 the LI is 53%. However the LI falls to 14% on E18 and reaches a nadir of ϳ2% at term (rat). This trend has been documented in a number of studies in both rats and mice, although there is variability in the absolute numbers reported. By postnatal days 2-4 the labeling index increases substantially to support postnatal growth (Kauffman et al., 1974) . That proliferation is increased in the T1␣(Ϫ/Ϫ) newborn lungs indicates that a key regulatory pathway, not yet identified, influencing cell division in the peripheral lung has been interrupted. Analyses of proliferation patterns during T1␣(Ϫ/Ϫ) lung development are planned to determine whether the increased PCNA expression observed at birth is a late event or whether there is sustained proliferation during lung development. We are not aware of other reports of this type of proliferation defect in lung at term although lungs of corticotropin-releasing-hormone (CRH) null mice also show increased PCNA staining in late fetuses (E18.5) (Muglia et al., 1999) . Whether the CRH animals show the expected drop in mitotic index at term was not reported.
In addition there is abnormal development of alveolar saccules in the absence of T1␣. The extremely reduced alveolar spaces, the marked decrease in flattened epithelial cells, and significantly reduced levels of Aqp-5 mRNA and protein are evidence of failure of morphogenesis of the normal number of type I cells, a process that normally occurs in the last 2-3 days of gestation (Adamson and Bowden, 1975; O'Hare and Townes, 1970) .
Exactly how type I cells form and what their parental cell lineage is are uncertain. There are tentative data for their derivation from postproliferative type II cells (Adamson and Bowden, 1975) , from a common precursor common to both type I and type II cells, and from different subpopulations committed early to type I or type II cell phenotypes (JoyceBrady and Brody, 1990; Williams and Dobbs, 1990) . Although debated, the developmental expression patterns of genes specific for adult type I and type II cells suggest that commitment to be type I or type II cells occurs early in organogenesis via separate cell populations. These interpretations are limited by the small number of type I cellspecific markers examined during development; only T1␣ has been studied in detail.
Overall the T1␣ null lung phenotype appears to be related to a general dysregulation of proliferation in the distal lung at the expense of correct differentiation. It is not clear whether proliferation is sustained because differentiation (due to loss of T1␣ protein and/or formation of very few type I cells) is blocked or whether differentiation is impaired because there is too much proliferation (epithelial cells continue to be produced but have no surface area available for formation of normal type I cells). Likewise current understanding of the overall null phenotype does not provide insight into which characteristics are due to the loss of T1␣ protein and which are due to failure of formation of type I cells.
Our findings indicate that T1␣ is not necessary for type II cell differentiation because their number and differentiation, as evaluated by surfactant gene expression, are normal in T1␣ knockout lungs. The cells contain lamellar bodies, express surfactant protein mRNAs at normal levels, express SP-B and SP-C proteins, and secrete abundant surfactant as evidenced by intraalveolar lamellar bodies and tubular myelin. Although SP-B or surfactant lipid deficiencies can result in respiratory failure (Clark et al., 1995) , these appear unlikely to contribute to respiratory failure in term T1␣ null mice.
The lung phenotype of the T1␣ mutants is unique for type I cell genes since inactivation of other type I cell genes does not affect type I cell formation or lung development. Aqp-5 Song et al., 2000) , caveolin-1 (Drab et al., 2001; Razani et al., 2001) , and ICAM-1 knockout mice (Xu et al., 1994) are viable and appear to have normal lungs at birth. Aqp-5 loss appears not to affect alveolar fluid clearance in neonates, making it unlikely that decreased Aqp-5 expression in T1␣ null mice contributes to their failure to breathe. Likewise caveolin-1 null mice seem normal at birth. Postnatally (4 -5 months), however, their lungs have thickened alveolar septae and endothelial cell hyperproliferation. The delay in this phenotype argues that the modest increase in caveolin-1 expression does not influence the T1␣ mutant phenotype. Similarly although null mutants of ICAM-1, expressed by type I cells, have reduced immune responses, they have no obvious developmental defects in the lung.
In contrast, glucocorticoid receptor (GR) (Cole et al., 1995) , CRH (Muglia et al., 1999) , and Sp3 transcription factor knockouts (Bouwman et al., 2000) , p21/p57 double knockout (Zhang et al., 1999) , and NF-1B (nuclear factor 1B) knockout (Grunder et al., 2002 ) produce a lung phenotype similar to the T1␣ knockout, although none is a type I cell differentiation gene. These mice fail to form normal distal airspaces and die of neonatal respiratory failure. The p21/p57 double knockout lungs do not show increased proliferation or apoptosis and are therefore likely to have differentiation defects. GR knockout mice show severe atelectasis with unaltered surfactant protein expression. Glucocorticoid-deficient CRH knockout lungs are similar to the T1␣ knockout with thickened alveolar septae and increased PCNA-staining in epithelial and mesenchymal cells on E18.5. Apoptotic cell numbers and surfactant protein mRNA levels in late gestation are normal. Although similarities between the CRH and T1␣ knockout mice are striking, mutations show opposite effects on cell number (DNA/ dry wet ratios). The CRH null animal is hypercellular, whereas the T1␣ mutant is slightly hypocellular. The morphology of the CRH knockout suggests that lungs may lack normal numbers of type I cells, raising the question of whether T1␣ expression is regulated by glucocorticoids. Low T1␣ expression could interfere with type I cell formation as in T1␣ null animals. Experiments are planned to test this possibility. Lungs of the T1␣ mutants also show significant similarities to lungs homozygous for the transcrip- tion factor NF-1B (nuclear factor 1B) (Grunder et al., 2002) , raising the possibility that decreased NF-1B contributes to the T1␣ null phenotype. NF-1B null newborns die within minutes after birth, apparently of respiratory failure, presumably from reduced expression of surfactant protein B. This finding is consistent with studies showing that NF1-B increases surfactant protein expression (Bachurski et al., 1997) . Preliminary microarray studies show that NF-1B2 is reduced (two-fold, n ϭ 5) in the absence of T1␣, although these data need to be validated. If loss of NF-1B contributes to the T1␣ phenotype, it likely does so by mechanisms other than interfering with surfactant protein expression.
We are currently using microarrays to obtain additional information on the genes whose expression is altered in lungs lacking T1␣. We have analyzed five wild-type and five homozygous E18.5 day lungs. There are statistically significant changes in a number of genes that are implicated in peripheral lung cell biology that might contribute to the T1␣ null phenotype. Among the altered genes are OTS-8 (identical to mouse T1␣) with decreased expression levels as anticipated, HFH-8 [Foxf1] ) that is increased in T1␣(Ϫ/Ϫ) lung, and prostaglandin synthase 1 (Ptgs-1, encoding cyclooxygenase 1 that produces PGE2) that is decreased. These changes have been confirmed by Northern blot (data not shown). OTS-8/T1␣ has the lowest ratio (T1␣ Ϫ/Ϫ)/(T1␣ ϩ/ϩ) in the microarray analysis and thus serves as an internal control. HFH-8 haplo-insufficient animals have high perinatal lethality due to lung abnormalities Lim et al., 2002; Mahlapuu et al., 2001 ), but the effects of increased HFH-8 are not known. Similarly we have confirmed by Northern blot a decrease in Ptgs1 mRNA in T1␣(Ϫ/Ϫ). This is particularly interesting because PGE2 inhibits peripheral lung fibroblast proliferation (Pan et al., 2001 ) and may therefore account for the increase in fibroblast proliferation observed in the knockout lung. Ptgs1/Cox1 have been suggested to be type I rather than type II cell products (Lipchik et al., 1990) , thus decreased Ptgs-1 may reflect failure of type I cell formation. Further studies on Ptgs1 gene, as well as other genes, will be helpful to determine whether the alterations observed in T1␣(Ϫ/Ϫ) lungs are related to the impaired epithelial-mesenchymal communication resulting from abnormal differentiation of type I cells in the absence of T1␣.
Of the genes known to be expressed by type I cells, T1␣ is the only one that seems to be essential for the timely development of alveoli and the air-blood barrier. We hypothesize that T1␣ could be directly involved in a pathway that induces cell-cycle exit and differentiation toward the type I cell phenotype of epithelial cells in late development. T1␣ could also be part of a type II-type I cell signaling pathway that inhibits proliferation in the distal lung once type I cells are differentiated. This cell-cell signaling could act via molecules present in the alveolar space, through intercellular junctions, or via mesenchymal-epithelial interactions. Whether T1␣ acts directly or is part of a more complex pathway is not known, nor are the molecules that may play important roles in the final proliferation vs differentiation equilibrium in the distal lung. T1␣ null mice are likely to be a helpful tool to understand the fate of the alveolar epithelial cells during lung organogenesis. Fig. 8 . Increased proliferation and normal apoptosis in T1␣ knockout lungs at birth. In (ϩ/ϩ) newborn lung PCNA staining is observed in upper airways, small bronchioles, and blood vessels excluding those in alveolar septae; distal lung cells are negative (A, C). In distal lungs of (Ϫ/Ϫ) newborns there is widespread, sustained proliferation of epithelial and mesenchymal cells shown by PCNA staining (B, D). At high magnification (E-G) PCNA staining of (Ϫ/Ϫ) lungs shows that both alveolar epithelial cells (E, arrow) and mesenchymal cells such as fibroblasts (F) express PCNA, while bronchiolar epithelial cells (G) do not. Tunel assays of newborn lung (H-I) indicate no differences in apoptotic cells between (ϩ/ϩ) and (Ϫ/Ϫ) newborns, a finding substantiated by nuclear counts. a, alveolar spaces; b, bronchioles; p, pleura; v, blood vessels. Paraffin sections (6 m); (E-G) counterstained with H&E; (H, I) counterstained with methyl green. Bars, A-B ϭ 100 m, C-D and H-I ϭ 30 m, E ϭ 10 m, F ϭ 15 m, G ϭ 25 m.
